Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia.
Weems JJ Jr, Steinberg JP, Filler S, Baddley JW, Corey GR, Sampathkumar P, Winston L, John JF, Kubin CJ, Talwani R, Moore T, Patti JM, Hetherington S, Texter M, Wenzel E, Kelley VA, Fowler VG Jr.
Weems JJ Jr, et al. Among authors: kubin cj.
Antimicrob Agents Chemother. 2006 Aug;50(8):2751-5. doi: 10.1128/AAC.00096-06.
Antimicrob Agents Chemother. 2006.
PMID: 16870768
Free PMC article.
Clinical Trial.